The most important goal of patients with generalized myasthenia gravis and their caregivers was to achieve stable disease. Patients with generalized myasthenia gravis (gMG) still have many unmet needs ...

Patients treated with combined low-dose rituximab regimen had better improvements and a higher proportion of favorable response in scale assessments at each follow-up visit. A simplified regimen of ...

There was no statistically significant association between the concentration of vatiquinone and Fridericia corrected QT interval. A supratherapeutic dose of 1400 mg of vatiquinone is safe and ...

This case report corresponds with others suggesting that tobacco use and asbestos exposure may be associated with the pathophysiology of IgG4-RD. An elderly male patient with a history of smoking and ...

Chronic lymphocytic leukemia (CLL) is a hematologic malignancy characterized by the clonal expansion of abnormal B lymphocytes. 1 Despite significant advancements in targeted therapies like Bruton’s ...

The differences in mast cell morphology and immunophenotype suggest the need for additional research into the role of mast cells in the liver in SM. A new study of patients with advanced systemic ...

Investigators found that prior to the exchange transfusion procedure, neonates with ABO blood group incompatibility had higher levels of serum total bilirubin and serum indirect bilirubin, and higher ...

PER has the advantage that it can be used in all patients with DEEs since it can be used regardless of the epilepsy syndrome. After 60 months of treatment with PER, the rates of patients who ...

Regarding non-neurological tests, the authors mentioned the Composite Autonomic Symptom Score (COMPASS-31) as a comprehensive self-assessment tool. Transthyretin amyloid polyneuropathy (ATTR-PN) ...

Which of the statements below about the diagnosis of immunoglobulin G4-related disease (IgG4-RD) are correct? Select one of the options for each question, then submit your answers to see how well you ...

Obeticholic acid, seladelpar, and elafibranor all significantly increased the biochemical response rate. Elafibranor seems to be slightly more effective than seladelpar as a second-line therapy in ...

Which of the statements below about the diagnosis of fetal and neonatal alloimmune thrombocytopenia (FNAIT) are correct? Select one of the options for each question, then submit your answers to see ...